doi:10.1530/REP-13-0251 Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC
However, before adding anything new to your regimen, though, consult your healthcare professional to make sure it is safe for you
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
That principle is not in dispute
Regular nutrient IV treatments are a practical solution to meeting the bodys need for this protein